3.0.0 6670 2023-01-11T13:43:02Z 2023-01-11T13:43:02Z House HR 2020-05-01 116 [Congressional Record Volume 166, Number 82 (Friday, May 1, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. ESHOO:H.R. 6670.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8[Page H1973]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-05-01T16:04:45Z The Heroes Act 116 6800 HR 2020-07-23 Committee on Small Business and Entrepreneurship. Hearings held. Related bill CRS 2020-05-01 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-05-01 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-05-01 Introduced in House IntroReferral 1000 9 Library of Congress E000215 Rep. Eshoo, Anna G. [D-CA-18] ANNA ESHOO D CA G. 18 N B001284 Rep. Brooks, Susan W. [R-IN-5] Susan Brooks R IN W. 5 2020-05-01 True R000577 Rep. Ryan, Tim [D-OH-13] TIM RYAN D OH 13 2020-05-12 False P000599 Rep. Posey, Bill [R-FL-8] Bill Posey R FL 8 2020-05-12 False L000566 Rep. Latta, Robert E. [R-OH-5] Robert Latta R OH E. 5 2020-06-08 False H001083 Rep. Horn, Kendra S. [D-OK-5] Kendra Horn D OK S. 5 2020-06-18 False H001056 Rep. Herrera Beutler, Jaime [R-WA-3] Jaime Herrera Beutler R WA 3 2020-06-29 False C001090 Rep. Cartwright, Matt [D-PA-8] Matt Cartwright D PA 8 2020-07-09 False Health Advisory bodies Congressional oversight Drug safety, medical device, and laboratory regulation Government studies and investigations Health technology, devices, supplies Manufacturing Prescription drugs Health 00 2020-05-01 Introduced in House 2020-05-12T21:03:35Z Prescription for American Drug Independence Act of 2020

This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) establish a committee of experts on drug-supply issues, (2) convene a symposium to recommend strategies for ending U.S. dependence on foreign manufacturing of critical drugs, and (3) report on the symposium's proceedings.

]]> Prescription for American Drug Independence Act of 2020 Display Title Prescription for American Drug Independence Act of 2020 Official Title as Introduced To provide for an exploration of strategies to increase domestic manufacturing and diversify the supply chain of critical drugs, and for other purposes. Introduced in House IH Short Title(s) as Introduced Prescription for American Drug Independence Act of 2020 Introduced in House IH Introduced in House 2020-05-01T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr6670ih/xml/BILLS-116hr6670ih.xml 2020-05-01 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.